[Virogenic component of exudative otitis media and tissue damages caused by it].
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections; D002648:Child; D002675:Child, Preschool; D002781:Cholesteatoma / Q000209:etiology / Q000382:microbiology; D004427:Ear Diseases / Q000209:etiology / Q000382:microbiology; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D012157:Mononuclear Phagocyte System; D009297:Nasal Mucosa / Q000382:microbiology; D010033:Otitis Media / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology / Q000473:pathology; D014777:Virus Diseases / Q000150:complications*
D000900:Anti-Bacterial Agents
Die virogene Komponente bei der exsudativen Mittelohrentzündung und die dadurch verursachten Gewebeschäden.